185 related articles for article (PubMed ID: 33125054)
21. CD318 is a ligand for CD6.
Enyindah-Asonye G; Li Y; Ruth JH; Spassov DS; Hebron KE; Zijlstra A; Moasser MM; Wang B; Singer NG; Cui H; Ohara RA; Rasmussen SM; Fox DA; Lin F
Proc Natl Acad Sci U S A; 2017 Aug; 114(33):E6912-E6921. PubMed ID: 28760953
[TBL] [Abstract][Full Text] [Related]
22. CD6 as a potential target for treating multiple sclerosis.
Li Y; Singer NG; Whitbred J; Bowen MA; Fox DA; Lin F
Proc Natl Acad Sci U S A; 2017 Mar; 114(10):2687-2692. PubMed ID: 28209777
[TBL] [Abstract][Full Text] [Related]
23. The anti-CD6 mAb, IOR-T1, defined a new epitope on the human CD6 molecule that induces greater responsiveness in T cell receptor/CD3-mediated T cell proliferation.
Osorio LM; Garcia CA; Jondal M; Chow SC
Cell Immunol; 1994 Mar; 154(1):123-33. PubMed ID: 7509726
[TBL] [Abstract][Full Text] [Related]
24. Recruitment of Sprouty1 to immune synapse regulates T cell receptor signaling.
Lee JS; Lee JE; Oh YM; Park JB; Choi H; Choi CY; Kim IH; Lee SH; Choi K
J Immunol; 2009 Dec; 183(11):7178-86. PubMed ID: 19915061
[TBL] [Abstract][Full Text] [Related]
25. Contribution of Evolutionary Selected Immune Gene Polymorphism to Immune-Related Disorders: The Case of Lymphocyte Scavenger Receptors
Casadó-Llombart S; Velasco-de Andrés M; Català C; Leyton-Pereira A; Lozano F; Bosch E
Int J Mol Sci; 2021 May; 22(10):. PubMed ID: 34070159
[TBL] [Abstract][Full Text] [Related]
26. Ablation of core fucosylation attenuates the signal transduction via T cell receptor to suppress the T cell development.
Liang W; Mao S; Li M; Zhang N; Sun S; Fang H; Zhang J; Gu J; Wang J; Li W
Mol Immunol; 2019 Aug; 112():312-321. PubMed ID: 31229844
[TBL] [Abstract][Full Text] [Related]
27. HIV-1 Nef limits communication between linker of activated T cells and SLP-76 to reduce formation of SLP-76-signaling microclusters following TCR stimulation.
Abraham L; Bankhead P; Pan X; Engel U; Fackler OT
J Immunol; 2012 Aug; 189(4):1898-910. PubMed ID: 22802418
[TBL] [Abstract][Full Text] [Related]
28. T cell activation regulates CD6 alternative splicing by transcription dynamics and SRSF1.
da Glória VG; Martins de Araújo M; Mafalda Santos A; Leal R; de Almeida SF; Carmo AM; Moreira A
J Immunol; 2014 Jul; 193(1):391-9. PubMed ID: 24890719
[TBL] [Abstract][Full Text] [Related]
29. T cell activation at the immunological synapse: vesicles emerge for LATer signaling.
Billadeau DD
Sci Signal; 2010 May; 3(121):pe16. PubMed ID: 20460646
[TBL] [Abstract][Full Text] [Related]
30. The CD6/ALCAM pathway promotes lupus nephritis via T cell-mediated responses.
Chalmers SA; Ayilam Ramachandran R; Garcia SJ; Der E; Herlitz L; Ampudia J; Chu D; Jordan N; Zhang T; Parodis I; Gunnarsson I; Ding H; Shen N; Petri M; Mok CC; Saxena R; Polu KR; Connelly S; Ng CT; Mohan C; Putterman C
J Clin Invest; 2022 Jan; 132(1):. PubMed ID: 34981775
[TBL] [Abstract][Full Text] [Related]
31. Lymphoproliferative disorders involving T helper effector cells with defective LAT signalosomes.
Roncagalli R; Mingueneau M; Grégoire C; Langlet C; Malissen B; Malissen M
Semin Immunopathol; 2010 Jun; 32(2):117-25. PubMed ID: 20107804
[TBL] [Abstract][Full Text] [Related]
32. Identification of a mouse protein homologous to the human CD6 T cell surface protein and sequence of the corresponding cDNA.
Robinson WH; Prohaska SS; Santoro JC; Robinson HL; Parnes JR
J Immunol; 1995 Nov; 155(10):4739-48. PubMed ID: 7594475
[TBL] [Abstract][Full Text] [Related]
33. Control of lymphocyte development and activation by negative regulatory transmembrane adapter proteins.
Simeoni L; Lindquist JA; Smida M; Witte V; Arndt B; Schraven B
Immunol Rev; 2008 Aug; 224():215-28. PubMed ID: 18759929
[TBL] [Abstract][Full Text] [Related]
34. Gene variation impact on prostate cancer progression: Lymphocyte modulator, activation, and cell adhesion gene variant contribution.
Casadó-Llombart S; Ajami T; Consuegra-Fernández M; Carreras E; Aranda F; Armiger N; Alcaraz A; Mengual L; Lozano F
Prostate; 2022 Oct; 82(14):1331-1337. PubMed ID: 35767366
[TBL] [Abstract][Full Text] [Related]
35. Tuning T Cell Activation: The Function of CD6 At the Immunological Synapse and in T Cell Responses.
Santos RF; Oliveira L; Carmo AM
Curr Drug Targets; 2016; 17(6):630-9. PubMed ID: 26028048
[TBL] [Abstract][Full Text] [Related]
36. Monoclonal antibodies to CD6 preferentially stimulate T-cell clones with gamma/delta rather than alpha/beta antigen receptors.
Pawelec G; Bühring HJ
Hum Immunol; 1991 Jul; 31(3):165-9. PubMed ID: 1832421
[TBL] [Abstract][Full Text] [Related]
37. A role for CD5 in TCR-mediated signal transduction and thymocyte selection.
Tarakhovsky A; Kanner SB; Hombach J; Ledbetter JA; Müller W; Killeen N; Rajewsky K
Science; 1995 Jul; 269(5223):535-7. PubMed ID: 7542801
[TBL] [Abstract][Full Text] [Related]
38. Characterization of mouse CD6 with novel monoclonal antibodies which enhance the allogeneic mixed leukocyte reaction.
Starling GC; Whitney GS; Siadak AW; Llewellyn MB; Bowen MA; Farr AG; Aruffo AA
Eur J Immunol; 1996 Apr; 26(4):738-46. PubMed ID: 8625962
[TBL] [Abstract][Full Text] [Related]
39. Sequential cooperation of CD2 and CD48 in the buildup of the early TCR signalosome.
Muhammad A; Schiller HB; Forster F; Eckerstorfer P; Geyeregger R; Leksa V; Zlabinger GJ; Sibilia M; Sonnleitner A; Paster W; Stockinger H
J Immunol; 2009 Jun; 182(12):7672-80. PubMed ID: 19494291
[TBL] [Abstract][Full Text] [Related]
40. Pattern Recognition by CD6: A Scavenger-Like Lymphocyte Receptor.
Sarukhan A; Martinez-Florensa M; Escoda-Ferran C; Carrasco E; Carreras E; Lozano F
Curr Drug Targets; 2016; 17(6):640-50. PubMed ID: 25777272
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
